Title:
INHIBITORS OF TYROSINE KINASES
Document Type and Number:
WIPO Patent Application WO2004005281
Kind Code:
A8
Abstract:
The invention relates to compounds of formula (I) Wherein the substituents R1, R2 and R4 have the meaning as set forth and explained in the description of the invention, to processes for the preparation of these compounds, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of a disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease, in particular leukaemia, and a method for the treatment of such disease.
Inventors:
BREITENSTEIN WERNER (CH)
FURET PASCAL (FR)
JACOB SANDRA (FR)
MANLEY PAUL WILLIAM (CH)
FURET PASCAL (FR)
JACOB SANDRA (FR)
MANLEY PAUL WILLIAM (CH)
Application Number:
PCT/EP2003/007198
Publication Date:
May 06, 2004
Filing Date:
July 04, 2003
Export Citation:
Assignee:
NOVARTIS AG (CH)
NOVARTIS PHARMA GMBH (AT)
BREITENSTEIN WERNER (CH)
FURET PASCAL (FR)
JACOB SANDRA (FR)
MANLEY PAUL WILLIAM (CH)
NOVARTIS PHARMA GMBH (AT)
BREITENSTEIN WERNER (CH)
FURET PASCAL (FR)
JACOB SANDRA (FR)
MANLEY PAUL WILLIAM (CH)
International Classes:
C07D401/04; A61K31/506; A61K31/5377; A61K31/55; A61P35/00; A61P35/02; A61P43/00; C07D401/14; C07D405/14; C07D417/14; (IPC1-7): C07D401/14; C07D405/14; A61K31/506; A61P35/00
Download PDF: